APRIUM PHARMACIE acquired by ARDIAN, BPIFRANCE & MACSF

Ardian's acquisition of Sagard's majority stake in Healthy Group, the parent company of Aprium Pharmacie, marks the end of a seven-year investment cycle characterized by the institutionalization of the platform and sustained organic growth of over 18% per annum between 2019 and 2023. This exit occurs as the French market for pharmacy groups is consolidating, with large urban pharmacies seeking to leverage dense central structures to optimize their transition to health service hubs. By partnering with Ardian's Growth team, Healthy Group's management, led by Emmanuel Schoffler, who is reinvesting significantly in the transaction, aims to execute a roadmap focused on densifying the national network through organic growth, enhancing omnichannel digital tools, and expanding the range of private-label products. Post-acquisition priorities include significantly accelerating the build-up program to consolidate a still-fragmented competitive landscape in France, where rivals are backed by peer funds, as well as initiating an international deployment strategy, transforming the French leader into a pan-European pharmaceutical services platform, with plans to enter new markets and expand its services offerings, thereby increasing its footprint in the European healthcare sector.